In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Varian Oncology Systems: At the Vanguard in Radiation Therapy

Executive Summary

With a huge installed base and a reputation for technology leadership, Varian is one of those rare companies: a market leader who innovates. Now, radiation therapy is being revolutionized by a new treatment approach, intensity modulated therapy. Against stiff competition from Siemens and GE, Varian is trying to leverage its leadership in linear accelerators into a winning position in the new treatment modality.

You may also be interested in...



Accuray: Building the Radiosurgery Market

Building a new product market is never easy, and the chances for a start-up in capital equipment are especially slim. Accuray has the scars to prove it. But after a long haul, it appears to be succeeding in building a market in radiosurgery.

Elekta: Growing from the Head Down

Elekta established its reputation with the Leksell Gamma Knife for neurosurgery. Now, after a turnaround, it is expanding into a comprehensive cancer care company.

How Varian Medical Stays On Top

Varian Medical Systems has built a strong franchise in the lucrative but complex specialty niche of radiation oncology through focused leadership, quality of product, and strong ties to customers. As it rolls out its current generation of planning and treatment systems, it has learned to be a provider of not just capital equipment, but also integrated systems. The challenge has been changing corporate culture.

Related Content

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

ID1132115

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel